• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LoSCAT评分在一大群青少年局限性硬皮病患者中用于活动度和组织损伤评估的可靠性。

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma.

作者信息

Agazzi Anna, Fadanelli Gloria, Vittadello Fabio, Zulian Francesco, Martini Giorgia

机构信息

Paediatric Rheumatology Unit, Department of Woman and Child Health, University of Padova, Via Giustiniani 2, 35128, Padova, Italy.

Paediatric Unit, Santa Chiara Hospital, Trento, Italy.

出版信息

Pediatr Rheumatol Online J. 2018 Jun 18;16(1):37. doi: 10.1186/s12969-018-0254-9.

DOI:10.1186/s12969-018-0254-9
PMID:29914516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6006585/
Abstract

OBJECTIVES

To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by clinicians with different experience in scoring and managing patients with JLS. Secondary aim was to compare LoSCAT and infrared thermography (IRT) in monitoring lesions over time.

METHODS

Consecutive children with Juvenile Localized Scleroderma (JLS) were blindly evaluated by three examiners with different experience in Paediatric Rheumatology and with no experience in LoSCAT use. At each visit, patients were assessed by LoSCAT and IRT. Sensitivity to change of LoSCAT and IRT was assessed in a group of patients 3-6 months later. Inter-rater reliability was assessed by Intraclass Correlation Coefficient (ICC) and variance analysis (ANOVA).

FINDINGS

Forty-seven patients (129 lesions) entered the study, and 26 (79 lesions) were re-evaluated with same modality after 4.5 (SD 1.5) months. mLoSSI showed excellent inter-rater reliability expressed by ICC 0.965 confirmed by ANOVA. Similarly, inter-rater reliability for LoSDI was good (ICC = 0.774) but worse concordance among examiners was observed. A comparable improvement of mLoSSI in all anatomic sites was noted by all examiners in 79 lesions examined in two subsequent visits and was consistent with thermography.

CONCLUSIONS

Different clinical experience in JLS did not influence clinical judgement in mLoSSI which showed excellent concordance, whereas LoSDI is less precise in damage assessment and not completely reliable in monitoring skin changes. Infrared thermography confirms to be a helpful tool for detecting disease activity and reliable in monitoring lesions over time.

摘要

目的

评估局限性硬皮病皮肤评估工具(LoSCAT)的两个指标,即改良局限性硬皮病皮肤严重程度指数(mLoSSI)和局限性硬皮病皮肤损伤指数(LoSDI),在不同经验的临床医生对青少年局限性硬皮病(JLS)患者进行评分和管理时的可靠性。次要目的是比较LoSCAT和红外热成像(IRT)在随时间监测病变方面的效果。

方法

由三位在儿科风湿病方面经验不同且无LoSCAT使用经验的检查者对连续的青少年局限性硬皮病(JLS)患儿进行盲法评估。每次就诊时,对患者进行LoSCAT和IRT评估。在一组患者3至6个月后评估LoSCAT和IRT对变化的敏感性。通过组内相关系数(ICC)和方差分析(ANOVA)评估评分者间的可靠性。

结果

47例患者(129个病变)进入研究,其中26例(79个病变)在4.5(标准差1.5)个月后以相同方式重新评估。mLoSSI显示出由ICC 0.965表示的出色评分者间可靠性,ANOVA证实了这一点。同样,LoSDI的评分者间可靠性良好(ICC = 0.774),但检查者之间的一致性较差。在两次后续就诊中检查的79个病变中,所有检查者都注意到mLoSSI在所有解剖部位有类似的改善,并且与热成像结果一致。

结论

在JLS方面不同的临床经验并未影响mLoSSI的临床判断,其显示出出色的一致性,而LoSDI在损伤评估中不太精确,在监测皮肤变化方面也不完全可靠。红外热成像被证实是检测疾病活动的有用工具,并且在随时间监测病变方面可靠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e7e/6006585/70dcaf40ec3f/12969_2018_254_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e7e/6006585/15dd162bc50e/12969_2018_254_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e7e/6006585/2c10b7928899/12969_2018_254_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e7e/6006585/70dcaf40ec3f/12969_2018_254_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e7e/6006585/15dd162bc50e/12969_2018_254_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e7e/6006585/2c10b7928899/12969_2018_254_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e7e/6006585/70dcaf40ec3f/12969_2018_254_Fig3_HTML.jpg

相似文献

1
Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma.LoSCAT评分在一大群青少年局限性硬皮病患者中用于活动度和组织损伤评估的可靠性。
Pediatr Rheumatol Online J. 2018 Jun 18;16(1):37. doi: 10.1186/s12969-018-0254-9.
2
The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.局限性硬皮病皮肤评估工具:在儿科临床人群中的变化反应性。
J Am Acad Dermatol. 2013 Aug;69(2):214-20. doi: 10.1016/j.jaad.2013.02.007. Epub 2013 Apr 4.
3
Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) adapted for use in adult patients: report from an initial validation study.本地化硬皮病皮肤评估工具(LoSCAT)适用于成年患者:初步验证研究报告。
Health Qual Life Outcomes. 2018 Sep 14;16(1):185. doi: 10.1186/s12955-018-1010-z.
4
Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change.使用局部硬皮病皮肤评估工具(LoSCAT)对硬斑病进行严重程度分类,并识别具有临床意义的变化。
Br J Dermatol. 2020 Feb;182(2):398-404. doi: 10.1111/bjd.18097. Epub 2019 Aug 14.
5
Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.局限性硬皮病皮肤损伤指数和医生对疾病损伤的整体评估的本地化开发和初步验证:概念验证研究。
Rheumatology (Oxford). 2010 Feb;49(2):373-81. doi: 10.1093/rheumatology/kep361. Epub 2009 Dec 14.
6
Detecting and quantifying activity/inflammation in localized scleroderma with thermal imaging.利用热成像检测和量化局限性硬皮病中的活动/炎症。
Skin Res Technol. 2019 Mar;25(2):118-123. doi: 10.1111/srt.12619. Epub 2018 Jul 21.
7
Non-invasive imaging and clinical skin scores in juvenile localized scleroderma.青少年局限性硬皮病的无创成像与临床皮肤评分
Rheumatology (Oxford). 2024 May 2;63(5):1332-1340. doi: 10.1093/rheumatology/kead380.
8
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.局限性硬皮病皮肤严重指数和医生对疾病活动的总体评估:开发局限性硬皮病结局指标的进展情况。
J Rheumatol. 2009 Dec;36(12):2819-29. doi: 10.3899/jrheum.081284. Epub 2009 Oct 15.
9
Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.幼年局限性硬皮病的疾病过程和长期转归:单中心儿科风湿病学经验及文献复习。
Autoimmun Rev. 2018 Jul;17(7):727-734. doi: 10.1016/j.autrev.2018.02.004. Epub 2018 May 3.
10
Narrow-band reflectance spectrophotometry and infrared thermography for assessment of skin lesions in localized scleroderma.窄带反射分光光度法和红外热成像技术在局限性硬皮病皮肤病变评估中的应用。
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):2451-2458. doi: 10.1111/jdv.18483. Epub 2022 Aug 17.

引用本文的文献

1
Clinical Application of Infrared Thermography in Rheumatic Diseases: A Systematic Review.红外热成像技术在风湿性疾病中的临床应用:一项系统综述
Mediterr J Rheumatol. 2025 Jan 30;36(2):159-192. doi: 10.31138/mjr.271024.ita. eCollection 2025 Jun.
2
Comparison of 3D facial photographs and clinical documentation in patients with craniofacial morphea.颅面硬斑病患者的三维面部照片与临床记录的比较
Skin Health Dis. 2024 Aug 10;4(6):e438. doi: 10.1002/ski2.438. eCollection 2024 Dec.
3
National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients.

本文引用的文献

1
Cone beam computed tomography for the assessment of linear scleroderma of the face.锥形束计算机断层扫描用于评估面部线状硬皮病。
Pediatr Rheumatol Online J. 2018 Jan 3;16(1):1. doi: 10.1186/s12969-017-0218-5.
2
Correlation of clinical tools to determine activity of localized scleroderma in paediatric patients.
Br J Dermatol. 2016 Feb;174(2):408-10. doi: 10.1111/bjd.14001. Epub 2015 Nov 20.
3
The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.局限性硬皮病皮肤评估工具:在儿科临床人群中的变化反应性。
全国儿童期起病硬皮病登记处I:来自首批341例青少年局限性硬皮病患者的见解。
J Scleroderma Relat Disord. 2024 Sep 23:23971983241272460. doi: 10.1177/23971983241272460.
4
Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma.甲氨蝶呤和霉酚酸酯在青少年局限性硬皮病中的疗效和耐受性的预先诱导。
AMRC Open Res. 2021 Sep 9;3:20. doi: 10.12688/amrcopenres.13008.1. eCollection 2021.
5
Superb microvascular imaging for evaluating the activity of juvenile localised scleroderma: a preliminary study.超微血流成像评估青少年局限性硬皮病的活动性:一项初步研究。
Eur Radiol. 2024 Oct;34(10):6376-6383. doi: 10.1007/s00330-024-10738-z. Epub 2024 Apr 23.
6
Recent Advances in Treatment of Systemic Sclerosis and Morphea.系统性硬皮病和硬斑病治疗的最新进展。
Am J Clin Dermatol. 2024 Mar;25(2):213-226. doi: 10.1007/s40257-023-00831-2. Epub 2023 Dec 12.
7
Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties.头部线性硬皮病——帕里-罗默伯格综合征和剑伤样硬皮病管理的最新进展:跨亚专业的快速范围综述
Eur J Rheumatol. 2020 Feb;7(Suppl1):S48-S57. doi: 10.5152/eurjrheum.2019.19183.
8
Why, how, and when to use color Doppler ultrasound for improving precision in the diagnosis, assessment of severity and activity in morphea.为什么、如何以及何时使用彩色多普勒超声来提高硬斑病诊断的准确性、严重程度评估及活动度评估。
J Scleroderma Relat Disord. 2019 Feb;4(1):28-34. doi: 10.1177/2397198318799244. Epub 2018 Sep 24.
J Am Acad Dermatol. 2013 Aug;69(2):214-20. doi: 10.1016/j.jaad.2013.02.007. Epub 2013 Apr 4.
4
Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach.甲氨蝶呤和泼尼松龙治疗深部硬斑病患者肌肉骨骼受累的疗效评价:联合 MRI 和临床方法。
AJR Am J Roentgenol. 2013 Apr;200(4):W376-82. doi: 10.2214/AJR.12.9335.
5
14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma).14兆赫超声检查作为硬斑病(局限性硬皮病)的一项疗效指标
Arch Dermatol. 2011 Sep;147(9):1112-5. doi: 10.1001/archdermatol.2011.243.
6
Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma.评估超声在评估青少年局限性硬皮病皮肤病变活动性中的应用。
Arthritis Care Res (Hoboken). 2011 May;63(5):735-42. doi: 10.1002/acr.20407.
7
Activity assessment in morphea using color Doppler ultrasound.应用彩色多普勒超声评估硬斑病的活动度。
J Am Acad Dermatol. 2011 Nov;65(5):942-8. doi: 10.1016/j.jaad.2010.08.027. Epub 2011 May 7.
8
Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.局限性硬皮病皮肤损伤指数和医生对疾病损伤的整体评估的本地化开发和初步验证:概念验证研究。
Rheumatology (Oxford). 2010 Feb;49(2):373-81. doi: 10.1093/rheumatology/kep361. Epub 2009 Dec 14.
9
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.局限性硬皮病皮肤严重指数和医生对疾病活动的总体评估:开发局限性硬皮病结局指标的进展情况。
J Rheumatol. 2009 Dec;36(12):2819-29. doi: 10.3899/jrheum.081284. Epub 2009 Oct 15.
10
Systemic sclerosis and localized scleroderma in childhood.儿童系统性硬化症和局限性硬皮病
Rheum Dis Clin North Am. 2008 Feb;34(1):239-55; ix. doi: 10.1016/j.rdc.2007.11.004.